Back to News
Market Impact: 0.22

MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'

Source: PR Newswire

Artificial IntelligenceTechnology & InnovationHealthcare & Biotech

A South Korean consortium involving Hanmi Pharmaceutical, Samsung SDS, and Selectstar is deploying a fine-tuned Korean Solar AI model on AIR Studio to automate pharmaceutical quality-document operations. The initiative is part of South Korea's MSIT-NIPA AX One-Stop Voucher Program, signaling targeted enterprise AI adoption in regulated life-sciences workflows.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.32

More News